0000950170-24-068050.txt : 20240603 0000950170-24-068050.hdr.sgml : 20240603 20240603163510 ACCESSION NUMBER: 0000950170-24-068050 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240531 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENXBIO Inc. CENTRAL INDEX KEY: 0001590877 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 471851754 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37553 FILM NUMBER: 241014200 BUSINESS ADDRESS: STREET 1: 9804 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-552-8181 MAIL ADDRESS: STREET 1: 9804 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: REGENXBIO, Inc. DATE OF NAME CHANGE: 20150116 FORMER COMPANY: FORMER CONFORMED NAME: ReGenX Biosciences, LLC DATE OF NAME CHANGE: 20131101 8-K 1 rgnx-20240531.htm 8-K 8-K
false000159087700015908772024-05-312024-05-31

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 31, 2024

 

 

REGENXBIO Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-37553

47-1851754

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

9804 Medical Center Drive

 

Rockville, Maryland

 

20850

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 240 552-8181

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

RGNX

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

REGENXBIO Inc. (the “Company”) held its Annual Meeting on May 31, 2024. The final voting results for each proposal considered at the Annual Meeting are set forth below. For more information on the proposals, see the Company’s definitive proxy statement on Schedule 14A filed with the SEC on April 4, 2024 (the “Proxy Statement”).

Proposal 1: By the following vote, the following three persons were elected to serve as Class III directors until the Company’s 2027 annual meeting of stockholders:

Nominee

Votes For

Votes Withheld

Broker Non-Votes

George Migausky

39,124,767

1,785,552

3,342,209

Kenneth T. Mills

39,258,562

1,651,757

3,342,209

David C. Stump

35,039,630

5,870,689

3,342,209

Proposal 2: By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024:

Votes For

Votes Against

Votes Abstaining

Broker Non-Votes

44,152,900

58,293

41,335

0

Proposal 3: By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement:

Votes For

Votes Against

Votes Abstaining

Broker Non-Votes

40,147,111

727,846

35,362

3,342,209

 

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

104

The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

REGENXBIO INC.

 

 

 

 

Date:

June 3, 2024

By:

/s/ Patrick J. Christmas II

 

 

 

Patrick J. Christmas II
Executive Vice President, Chief Legal Officer

 

 EX-101.SCH 2 rgnx-20240531.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document And Entity Information
May 31, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 31, 2024
Entity Registrant Name REGENXBIO Inc.
Entity Central Index Key 0001590877
Entity Emerging Growth Company false
Entity File Number 001-37553
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 47-1851754
Entity Address, Address Line One 9804 Medical Center Drive
Entity Address, City or Town Rockville
Entity Address, State or Province MD
Entity Address, Postal Zip Code 20850
City Area Code 240
Local Phone Number 552-8181
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol RGNX
Security Exchange Name NASDAQ
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports rgnx-20240531.htm rgnx-20240531.xsd http://xbrl.sec.gov/dei/2024 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "rgnx-20240531.htm": { "nsprefix": "rgnx", "nsuri": "http://regenxbio.com/20240531", "dts": { "inline": { "local": [ "rgnx-20240531.htm" ] }, "schema": { "local": [ "rgnx-20240531.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_8fdaa0ef-beff-45bc-8071-a1ea2cb37d97", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "rgnx-20240531.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_8fdaa0ef-beff-45bc-8071-a1ea2cb37d97", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "rgnx-20240531.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://regenxbio.com/20240531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 12 0000950170-24-068050-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-068050-xbrl.zip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rgnx-20240531_htm.xml IDEA: XBRL DOCUMENT 0001590877 2024-05-31 2024-05-31 false 0001590877 8-K 2024-05-31 REGENXBIO Inc. DE 001-37553 47-1851754 9804 Medical Center Drive Rockville MD 20850 240 552-8181 false false false false Common Stock, par value $0.0001 per share RGNX NASDAQ false